tiprankstipranks
Microvision (MVIS)
NASDAQ:MVIS

Microvision (MVIS) AI Stock Analysis

3,021 Followers

Top Page

MVIS

Microvision

(NASDAQ:MVIS)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
$0.68
▼(-28.11% Downside)
Action:ReiteratedDate:03/17/26
The score is held down primarily by weak financial performance (shrinking revenue, sustained losses, and ongoing cash burn). Technicals also remain bearish with the stock below key moving averages, despite oversold readings. Positives from the earnings call (2026 revenue guidance, acquisition-driven traction, and cost reductions) and recent liquidity actions provide some offset, but execution and listing/financing risks remain significant.
Positive Factors
Expanded product portfolio
Acquiring Luminar and Scantinel built a full-stack offering (short- and long-range sensors, FMCW, perception software). This diversifies product-market fit across automotive, industrial and defense, improving competitive position and enabling multiple pathways to sustainable revenue over the next several years.
Negative Factors
Severe revenue decline
Revenue has contracted sharply, showing the company's top-line remains very small and volatile. Persistently low sales limit operating leverage, make fixed costs harder to cover, and mean that even successful product ramps must scale materially to change the loss profile and fund reinvestment organically.
Read all positive and negative factors
Positive Factors
Negative Factors
Expanded product portfolio
Acquiring Luminar and Scantinel built a full-stack offering (short- and long-range sensors, FMCW, perception software). This diversifies product-market fit across automotive, industrial and defense, improving competitive position and enabling multiple pathways to sustainable revenue over the next several years.
Read all positive factors

Microvision (MVIS) vs. SPDR S&P 500 ETF (SPY)

Microvision Business Overview & Revenue Model

Company Description
MicroVision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms, and ...
How the Company Makes Money
MicroVision makes money primarily by selling lidar-related products and services and, where applicable, licensing its technology. Key revenue streams include: (1) Product revenue from sales of lidar sensors and associated components/subsystems to ...

Microvision Earnings Call Summary

Earnings Call Date:Mar 04, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 23, 2026
Earnings Call Sentiment Neutral
The call presents a balanced picture: strong strategic progress from the Luminar and Scantinel acquisitions, an expanded product portfolio, renewed customer engagement and clear 2026 revenue guidance are important positives. However, these operational gains are juxtaposed with sharply reduced 2025 revenue, substantial noncash impairments, continued high cash burn and anticipated restructuring charges. The company has taken steps to improve efficiency and has liquidity actions in place, but execution risk remains as near-term financials rely on converting acquired customer contracts and ramping new products.
Positive Updates
Defense and Security Market Momentum
Increased pull from defense customers, driven by Scantinel's 1550 nm FMCW (invisible to night vision) and long-range capabilities; MOVIA L shipments began to a European security & defense OEM in December with repeat orders continuing into 2026.
Negative Updates
Sharp Revenue Decline in FY2025 and Q4
Q4 2025 revenue was $0.2 million versus $1.7 million in Q4 2024 (an ~88% decrease); full year 2025 revenue was $1.2 million versus $4.7 million in 2024 (a ~74% decrease), primarily due to a one-time last-time buy in 2024 for legacy Ibeo sensors.
Read all updates
Q4-2025 Updates
Negative
Defense and Security Market Momentum
Increased pull from defense customers, driven by Scantinel's 1550 nm FMCW (invisible to night vision) and long-range capabilities; MOVIA L shipments began to a European security & defense OEM in December with repeat orders continuing into 2026.
Read all positive updates
Company Guidance
MicroVision guided calendar-year 2026 revenue of $10.0–$15.0 million and total cash use in operations plus CapEx of $65.0–$70.0 million, noting that the outlook reflects conversion of Luminar revenues and prior MicroVision plans and that MOVIA S production is expected to start in early Q4 to help drive sales; management also said margins should be positive. For context, the company ended Q4 2025 with $74.8 million in cash, cash equivalents and investment securities, $43.0 million available under its ATM facility, recently issued $43.0 million of senior secured convertible notes (to repay ~$19.5M of prior note principal and interest), and reported FY2025 revenue of $1.2M (Q4 $0.2M), cash used in operations of $58.7M for FY2025 (Q4 $15.4M), FY total operating expenses of $65.5M (including $13.4M noncash asset impairment) with adjusted cash-based OpEx of $45.5M (down $14.4M or 24% vs. 2024), FY capex of $0.7M (Q4 $0.2M), Q4 noncash impairment/commitment charges of $29.4M (including $16.0M cost of revenue and $13.4M operating expense), and anticipated 2026 impairment and restructuring charges of approximately $8–$12M and $1–$2M, respectively.

Microvision Financial Statement Overview

Summary
Financials remain weak with very small and shrinking revenue, deeply negative margins, large ongoing net losses, and continued negative operating/free cash flow. Leverage improved versus 2024, but persistent losses and cash burn continue to erode flexibility and raise funding risk.
Income Statement
12
Very Negative
Balance Sheet
34
Negative
Cash Flow
18
Very Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.21M4.70M7.26M664.00K2.50M
Gross Profit-17.34M-2.83M4.49M564.00K2.50M
EBITDA-63.56M-70.98M-83.07M-53.15M-42.92M
Net Income-94.98M-96.92M-82.84M-53.09M-43.20M
Balance Sheet
Total Assets103.12M121.16M129.63M115.00M130.22M
Cash, Cash Equivalents and Short-Term Investments74.83M74.70M73.78M82.71M115.37M
Total Debt36.77M51.64M15.04M15.70M6.27M
Total Liabilities47.57M72.39M33.83M25.25M17.47M
Stockholders Equity55.55M48.77M95.80M89.74M112.75M
Cash Flow
Free Cash Flow-59.40M-68.91M-69.03M-42.38M-31.90M
Operating Cash Flow-58.72M-68.54M-67.09M-38.02M-29.40M
Investing Cash Flow-24.65M2.67M21.82M-38.07M-35.32M
Financing Cash Flow60.87M72.89M72.44M14.31M131.16M

Microvision Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.95
Price Trends
50DMA
0.70
Negative
100DMA
0.81
Negative
200DMA
1.00
Negative
Market Momentum
MACD
-0.02
Negative
RSI
46.05
Neutral
STOCH
49.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MVIS, the sentiment is Negative. The current price of 0.95 is above the 20-day moving average (MA) of 0.63, above the 50-day MA of 0.70, and below the 200-day MA of 1.00, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 46.05 is Neutral, neither overbought nor oversold. The STOCH value of 49.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MVIS.

Microvision Risk Analysis

Microvision disclosed 29 risk factors in its most recent earnings report. Microvision reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Microvision Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$206.56M42.820.51%2.25%6.17%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
55
Neutral
$654.63M96.461.59%-7.46%-39.98%
53
Neutral
$701.74M-13.49-70.17%36.85%-77.93%
52
Neutral
$489.21M23.27-30.23%3.02%90.87%
47
Neutral
$238.09M-4.46-9.42%5.93%-9.51%29.57%
45
Neutral
$190.94M-1.68-137.37%-67.66%13.39%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MVIS
Microvision
0.62
-0.58
-48.17%
KOPN
Kopin
2.68
1.86
224.85%
LPTH
Lightpath Technologies
12.16
10.40
590.91%
MEI
Methode Electronics
6.72
1.27
23.26%
RELL
Richardson Electronics
14.43
6.51
82.10%
VPG
Vishay Precision Group
49.23
29.13
144.93%

Microvision Corporate Events

Business Operations and StrategyPrivate Placements and Financing
MicroVision Leadership Boosts Stake, Signaling Confidence in Strategy
Positive
Mar 16, 2026
On March 16, 2026, MicroVision announced that all of its executive officers and U.S.-based board members committed to buy company common stock on market terms, signaling internal confidence in its strategy to reshape the lidar industry. The move f...
Business Operations and StrategyPrivate Placements and Financing
MicroVision Raises Capital Through New Convertible Notes Deal
Positive
Feb 24, 2026
On February 23, 2026, MicroVision entered into a securities purchase and exchange agreement with institutional investor High Trail Capital to issue $43 million in senior secured zero-coupon convertible notes maturing March 1, 2028, exchanging abou...
Business Operations and StrategyM&A Transactions
MicroVision Schedules Investor Update on Post-Acquisition Strategy
Positive
Feb 24, 2026
MicroVision announced on February 24, 2026 that it will host a video-enabled business update and fireside chat on February 25, 2026, led by Chief Executive Officer Glen DeVos and moderated by McKinsey Company Senior Partner Emeritus Hans-Werner K...
Business Operations and StrategyLegal ProceedingsM&A Transactions
MicroVision to Acquire Luminar Lidar Assets in Bankruptcy
Positive
Jan 30, 2026
On January 26, 2026, MicroVision entered into an asset purchase agreement to acquire from Luminar Technologies key assets of Luminar’s lidar sensor business, including intellectual property and inventory related to the Iris and Halo sensors,...
Delistings and Listing ChangesRegulatory Filings and Compliance
MicroVision Receives Nasdaq Deficiency Notice on Bid Price
Negative
Jan 16, 2026
On January 12, 2026, MicroVision, Inc. received a deficiency notice from Nasdaq after its shares traded below the $1 minimum bid price requirement for 30 consecutive business days, putting the company out of compliance with Nasdaq’s continue...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 17, 2026